Literature DB >> 22929232

Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors.

XianYun Jiao1, David J Kopecky, JinSong Liu, JinQian Liu, Juan C Jaen, Mario G Cardozo, Rajiv Sharma, Nigel Walker, Holger Wesche, Shyun Li, Ellyn Farrelly, Shou-Hua Xiao, Zhulun Wang, Frank Kayser.   

Abstract

Two classes of ACK1 inhibitors, 4,5,6-trisubstituted furo[2,3-d]pyrimidin4-amines and 4,5,6-trisubstituted 7H-pyrrolo[2,3-d]pyrimidin-4-amines, were discovered and evaluated as ACK1 inhibitors. Further structural refinement led to the identification of potent and selective dithiolane inhibitor 37.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22929232     DOI: 10.1016/j.bmcl.2012.08.020

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Kinetic Resolution via Rh-Catalyzed C-C Activation of Cyclobutanones at Room Temperature.

Authors:  Lin Deng; Yue Fu; Siu Yin Lee; Chengpeng Wang; Peng Liu; Guangbin Dong
Journal:  J Am Chem Soc       Date:  2019-10-02       Impact factor: 15.419

2.  Efficient one-pot synthesis of novel and diverse furo[2,3-d] pyrimidinediones and thioxofuro[2,3-d] pyrimidineones by the rhodium (II) pivalate-catalyzed reactions of cyclic diazo compounds.

Authors:  Krishna Bahadur Somai Magar; Yong Rok Lee; Sung Hong Kim
Journal:  Mol Divers       Date:  2013-08-02       Impact factor: 2.943

3.  Development of novel ACK1/TNK2 inhibitors using a fragment-based approach.

Authors:  Harshani R Lawrence; Kiran Mahajan; Yunting Luo; Daniel Zhang; Nathan Tindall; Miles Huseyin; Harsukh Gevariya; Sakib Kazi; Sevil Ozcan; Nupam P Mahajan; Nicholas J Lawrence
Journal:  J Med Chem       Date:  2015-03-17       Impact factor: 7.446

4.  Estimation of relative free energies of binding using pre-computed ensembles based on the single-step free energy perturbation and the site-identification by Ligand competitive saturation approaches.

Authors:  E Prabhu Raman; Sirish Kaushik Lakkaraju; Rajiah Aldrin Denny; Alexander D MacKerell
Journal:  J Comput Chem       Date:  2016-10-26       Impact factor: 3.376

Review 5.  ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferation.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  Cancer Lett       Date:  2013-04-15       Impact factor: 8.679

6.  Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.

Authors:  Julia E Maxson; Melissa L Abel; Jinhua Wang; Xianming Deng; Sina Reckel; Samuel B Luty; Huahang Sun; Julie Gorenstein; Seamus B Hughes; Daniel Bottomly; Beth Wilmot; Shannon K McWeeney; Jerald Radich; Oliver Hantschel; Richard E Middleton; Nathanael S Gray; Brian J Druker; Jeffrey W Tyner
Journal:  Cancer Res       Date:  2015-12-17       Impact factor: 12.701

7.  Effect of set up protocols on the accuracy of alchemical free energy calculation over a set of ACK1 inhibitors.

Authors:  José M Granadino-Roldán; Antonia S J S Mey; Juan J Pérez González; Stefano Bosisio; Jaime Rubio-Martinez; Julien Michel
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

8.  A one-pot, multicomponent reaction for the synthesis of novel 2-alkyl substituted 4-aminoimidazo[1,2-a][1,3,5]triazines.

Authors:  Felicia Phei Lin Lim; Lin Yuing Tan; Edward R T Tiekink; Anton V Dolzhenko
Journal:  RSC Adv       Date:  2018-06-12       Impact factor: 3.361

9.  Ack promotes tissue growth via phosphorylation and suppression of the Hippo pathway component Expanded.

Authors:  Lianxin Hu; Jiajun Xu; Meng-Xin Yin; Liguo Zhang; Yi Lu; Wenqing Wu; Zhaoyu Xue; Margaret S Ho; Guanjun Gao; Yun Zhao; Lei Zhang
Journal:  Cell Discov       Date:  2016-02-23       Impact factor: 10.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.